Investigating the potential of prebiotics to rebalance and maintain health
Task Force Information
Objectives
The Prebiotics Task Force advances understanding of how prebiotics interact with the gut microbiota and influence human health, moving from observed benefits towards clear biological mechanisms.
Why It Matters
For public health, stronger mechanistic evidence supports evidence-based strategies that protect consumers and help people make informed choices about products intended to support health.
For companies, mechanistic evidence helps guide product innovation, identify effective prebiotic solutions and strengthen scientific substantiation of health benefits.
Task Force Members
| Clémentine Thabuis-Chair | Roquette | Senior Nutrition and Health Research Manager | FR |
| Elaine Vaughan-Vice-Chair | Cosun | Health Science & Regulatory Affairs | NL |
| Kristin Verbeke, Co-Chair* | Translational Research Center for Gastrointestinal Disorders (TARGID) | Researcher | BE |
| Paul de Vos* | Centre for Healthy Eating & Food Innovation (HEFI), Maastricht University) | Professor | NL |
| Aurélie Goux | Cargill | Senior Scientist in Nutrition and Health | BE |
| Jessica Van Harsselaar | Südzucker Group | Manager Nutrition Science | DE |
| Georgina Dodd | Clasado | R&D Senior Scientist | UK |
| Sofia Forssten | IFF | Lead Scientist | FI |
| Damien Guillemet | Nexira | Scientific Development Director | FR |
| Alexandra Meynier | Mondelez International | Nutrition Scientist | FR |
| Robert Steinert | DSM-Firmenich | Principal Scientist | DK |
| Bernd Stahl | Danone Nutricia | Associate Professor | NL |
*Scientific Advisor
For more detailed information, please contact Léonie Lang at llang@ilsieurope.be
Activity Overview
Ongoing
- Markers of the Gut Microbiota
The group aims to identify key markers for assessing microbiota improvement, focusing on measurable indicators of microbiota composition. The activity is shared with the Probiotics Task Force.
Start date: 2024 - End date: 2026
- Role of Prebiotics in Better Managing Women’s Health
The Expert Group will aim to understand the extent and mechanisms by which prebiotics impact the women’s health in different stages of life.
Start date: 2025 - End date: 2027
- Shaping Metabolic Health: GLP-1 Receptor Agonists, Prebiotics, and the Gut-Brain Axis
The research group will explore how prebiotics support weight control, both independently and alongside GLP-1 receptor agonists. A workshop on GLP-1 analogues and health outcomes is planned for Q1 2026. The Expert Group will investigate key mechanisms, such as SCFA production, gut hormone stimulation, and microbiome modulation—with a focus on enhancing satiety, metabolic regulation, and treatment adherence. A key objective is to evaluate whether prebiotics can help reduce GLP-1–related side effects, such as gastrointestinal discomfort.
Start Date: 2026 - End Date: 2028
In the Pipeline
In 2027, the Task Force will develop a new activity proposal.
While the exact scope is still to be defined, prioritised topics include:
- Interindividual variability in response to prebiotics: prebiotics and specific place of fermentation (from small intestine to distal colon);
- Consumer interest and understanding of fibers and prebiotics: the role of prebiotics in GLP1-RA users and ex-users.
Expert Groups
Markers of the Gut Microbiota
Background and Objectives
Changes in the gut microbiota are increasingly linked to health outcomes, but consistent markers for measuring these effects are still lacking. This Expert Group aims to establish standardized markers for assessing improvements in gut microbiota composition and activity following dietary interventions. They will evaluate microbial composition, metabolites, enzymatic systems, mucosal integrity and immune responses to identify the most informative and predictive parameters for human health and strengthen the evidence linking prebiotic-induced microbiota changes to health benefits.
Output
Open-access peer-reviewed publication.
Expert Group Members
| Sahar El Aidy - Chair | University of Amsterdam | Professor of Microbiome Engineering | NL |
| Renate Akkerman | Maastricht University | Assistant Professor | NL |
| Paul de Vos | Maastricht University | Professor | NL |
| Kristin Verbeke | KU Leuven | Researcher | BE |
| Anisha Wijeyesekera | University of Reading | Associate Professor in Human Microbiome and Metabolome Studies | UK |
| Jonathan Swann | University of Southampton | Professor of Biomolecular Medicine | UK |
| Sofia Forssten | IFF | Lead Scientist | FI |
| Damien Guillemet | Nexira | Scientific Development Director | FR |
| Alexandra Meynier | Mondelez | Nutrition Scientist | FR |
| Clémentine Thabuis | Roquette | Senior Nutrition and Health Research Manager | FR |
| Delphine Saulnier | Novonesis | Science Manager | DK |
| Holly Sedgwick | University of Reading | PhD Candidate | UK |
Role of Prebiotics in Better Managing Women’s Health
Background and Objectives
Women’s health is shaped by complex interactions between the microbiome, immune system, metabolism and hormonal changes across the life course. This Expert Group aims to assess how prebiotics may support women’s health from puberty through reproductive years, pregnancy, menopause and ageing. They will review current evidence on prebiotic interventions and health outcomes, examine underlying mechanisms including microbial composition, metabolites, barrier function, immune regulation and estrogen metabolism, and identify key research gaps to guide more inclusive and hormone-informed future studies.
Output
Open-access peer-reviewed publication
Expert Group Members
| Clementine Thabuis | Roquette | Senior Nutrition & Health Research Manager | FR |
| David Vauzour | University of East Anglia | Associate Professor | UK |
| Verlee Dam | Cosun | Health Science & Regulatory Affairs Specialist | Nl |
| Georgina Dodd | Clasado | R&D Senior Scientist | UK |
| Isabel Erreygers | University of Antwerp | PhD Student | BE |
| Paul de Vos | Maastricht University | Professor | NL |
| Reeta Ala Jaakkola | IFF | Science Liaison, Women’s Health Lead | FI |
| Samira Prado | Örebro University | Assistant Professor | SE |
| Sarah Lebeer | University of Antwerp | Research Professor | BE |
| Siobhain O'Mahony | University College Cork | Professor of Neurobiology | IE |
Shaping Metabolic Health: GLP-1 Receptor Agostist, Prebiotics, and the Gut-Brain Axis
Background and Objectives
Metabolic, cognitive and mental health are increasingly linked to interactions between the gut, brain and metabolic signalling pathways. This workshop explored how GLP-1 receptor agonists and prebiotic strategies may influence appetite regulation, metabolic health, cognition and mental well-being through the gut–brain axis. Experts reviewed emerging evidence, discussed real-world clinical implications, and identified key knowledge gaps and priority research questions to guide future collaborative research.
Output
Open-access peer-reviewed publication.
Expert Group Members
| Robert Steinert | dsm-Firmenich | Principal Scientist | UK |
| Clémentine Thabuis | Roquette | Senior Nutrition & Health Research Manager | FR |
| Jessica Van Harsselaar | Sudzucker Group | Manager Nutrition Science | DE |
| Elaine Vaughan | Cosun | Health Science & Regulatory Affairs | NL |
| Georgia Chatonidi | Örebro University | Postdoctoral Researcher | SE |
| Louise Dye | University of Sheffield | Professor of Nutrition and Behaviour | UK |
| Sandrine Thuret | King's College London | Professor of Neurosciences | UK |
| Wim Vandenberghe | University of Antwerp | Professor of Neurology | BE |
| David Vauzour | University of East Anglia | Associate Professor | UK |
Publications
Oldest to Newest
Prebiotic Effects: Metabolic and Health Benefits
2010
Probiotics, Prebiotics and the Gut Microbiota
2013
ILSI Europe Concise Monograph. 2013:1-32. Commissioned by the Prebiotics and Probiotics Task Forces. Translation available in Portuguese and Japanese.
Towards Microbial Fermentation Metabolites as Markers for Health Benefits of Prebiotics
2015
Nutrition Research Reviews. 2015;28:42–66. Commissioned by the Prebiotics Task Force.
Gut Microbiota Functions: Metabolism of Nutrients and other Food Components
2017
European Journal of Nutrition 2018;57(1):1-24. Commissioned by the Functional Foods and the Prebiotics Task Forces.
Systematic Review of the Effects of the Intestinal Microbiota on Selected Nutrients and Non-Nutrients
2017
European Journal of Nutrition 2018;57(1):25-49. Commissioned by the Functional Foods and the Prebiotics Task Forces.
Multimedia
Completed Expert Groups
Overview of completed activities
- Role of prebiotics in bacterial and viral infection, and vaccination efficiency
- “Prebiotics Sandpit” Workshop: Identifiyng Knowledge Gaps and a Roadmap for Building an Health Claims Portfolio
- Role of prebiotics in cognitive functioning: What do we know and where to go next?
- Prediction of individual responses to prebiotics and probiotics intervention (collaboration with Probiotics Task Force)
- Understanding the Relationship Between the Molecular Structure and the Effects of Prebiotic Compounds on Microbiota and its Metabolites
- Joint nutrition cluster activity on ‘mechanistic insights into the gut-brain axis' in collaboration with Early Nutrition and Long-Term Health; Health Benefit Assessment of Foods; Nutrition, Immunity & Inflammation; Nutrition & Brain Health; and Probiotics Task Forces
- Updated concise monograph - Dietary Probiotics, Prebiotics and the Gut Microbiota in Human Health (collaboration with Probiotics Task Force)
- Revealing the Mechanistic Role in Human Physiology and Beneficial Aspects of Short Chain Fatty Acid (SCFA) Production in the Gastro-Intestinal Tract (GIT)